Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Helena Losa-Puig"'
Autor:
Nadia Magallanes-Peláez, Alejandra Mariño-Noya, Nerea Puga-González, Helena Losa-Puig, Laura González-Rodríguez, Emilio Couceiro-Naveira, Carlos López-Ramón y Cajal
Publikováno v:
Revista Chilena de Obstetricia y Ginecología, Vol 89, Iss 6 (2024)
Introduction: Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness. SARS-CoV-2 is currently a global health issue. Physiologic
Externí odkaz:
https://doaj.org/article/c11553d7f85d48faad309ccb32f00de1
Autor:
Manuel Sánchez-Prieto, Helena Losa-Puig, Natanael A. Domínguez-Osorio, Marta Sanjosé-Alemany, Fernando Losa-Domínguez, Rafael Sánchez-Borrego
Publikováno v:
Revista Chilena de Obstetricia y Ginecología, Vol 88, Iss 2 (2023)
El síndrome premenstrual es un trastorno común en mujeres en edad reproductiva y se caracteriza por al menos un síntoma físico, emocional o conductual, que aparece en la fase lútea del ciclo menstrual y se resuelve poco después del inicio de la
Externí odkaz:
https://doaj.org/article/38cff3ba77c3439a93d87dc5de466543
Autor:
Marta Juanes-González, Ana Calderón-Valdiviezo, Helena Losa-Puig, Marta González-Salvador, Roger Valls-Foix, Marc León-Pérez, Luís Pueyo-Antón, Celia Lozano-Paz, Maite Franco-Romero, Josep Vidal-Alaball, Anna Puigdellívol-Sánchez
BACKGROUND Some authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c13e8b1e53c07c7caf2f72273b50153d
https://doi.org/10.21203/rs.3.rs-1272080/v1
https://doi.org/10.21203/rs.3.rs-1272080/v1
Autor:
Maite Franco-Romero, Marta González-Salvador, Marc León-Pérez, Luís Pueyo-Antón, Roger Valls-Foix, Celia Lozano-Paz, Marta Juanes-González, Helena Losa-Puig, Ana Calderón-Valdiviezo, Josep Vidal-Alaball, Anna Puigdellívol-Sánchez
BACKGROUNDSome authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adce8f807df63a93f9938085268cd849
https://doi.org/10.1101/2021.11.17.21265440
https://doi.org/10.1101/2021.11.17.21265440